Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of lower doses of primaquine
compared to the dose recommended by the WHO for reducing P. falciparum gametocytes in the
infected human host to prevent transmission of falciparum malaria to the anopheles mosquito
vector.